![discount label](https://static.cymitquimica.com/public/img/discount.png)
![Nessuna immagine](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
![Targetmol Targetmol logo](https://static.cymitquimica.com/public/img/partners/targetmol.png)
Informazioni sul prodotto
E2730 is a selective and noncompetitive inhibitor of the gamma-aminobutyric acid (GABA) transporter 1 (GAT1) that exhibits oral availability as well as antiepileptic properties. Its inhibition of GAT1 is dependent on the prevailing GABA concentrations and specifically targets GAT1-mediated GABA uptake. Demonstrating in vivo effectiveness, E2730 has been tested at doses ranging from 5-50 mg/kg orally in various models, including the rat amygdala kindling and the mouse corneal kindling models, as well as in drug-resistant psychomotor epilepsy, fragile X syndrome at 2.5-300 mg/kg, and Dravet syndrome at dosages of 10 mg/kg and 20 mg/kg [1].
Proprietà chimiche
Richiesta tecnica su: TM-T79399 E2730
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.